Somerset Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Somerset Trust's XBI Position: Q1 2015 in Review
Somerset Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2015, closing a stake of 16,974 shares — an estimated $1.05M sold.
Somerset Trust first reported a position in XBI in Q4 2013 and held it in 5 quarters. The position peaked at $1.79M in Q2 2014. 180 funds tracked by Wall St. Rank hold XBI as of Q1 2015.
- Somerset Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2015 after selling out during the quarter.
- Somerset Trust sold 16,974 State Street SPDR S&P Biotech ETF shares in Q1 2015, an estimated $1.05M.
- Somerset Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and held it in 5 quarters.
- Somerset Trust's State Street SPDR S&P Biotech ETF position peaked at $1.79M in Q2 2014.
- 180 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2015.
Based on Somerset Trust's 13F filing for Q1 2015, filed 16 Apr 2015.